Granules India Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst collects, processes, and evaluates adverse event reports for drugs and clinical trial products to ensure patient safety and regulatory compliance. Day to day, they perform case intake, data entry into safety databases, coding with MedDRA, and assist in writing aggregate reports like PSURs and PBRERs. In a fast-growing company like Granules India, they work closely with regulatory affairs, medical affairs, and quality teams to meet global pharmacovigilance requirements.

Role and Technical Knowledge

1. 1

   What is the difference between an adverse event (AE) and a serious adverse event (SAE)? Give examples.

   Define AE as any untoward medical occurrence and SAE using ICH criteria (death, life-threatening, hospitalisation, disability, congenital anomaly, or medically significant). Provide one example for each.

2. 2

   Walk me through the steps you follow from receiving an adverse event report to closing the case in a safety database.

   Cover intake, triage, duplicate check, data entry, MedDRA coding, seriousness and causality assessment, quality review, medical review, and submission within regulatory timelines (e.g., 15 days for SAE).

3. 3

   What is MedDRA and why is it used in pharmacovigilance? Explain its hierarchy.

   MedDRA is a standardised medical dictionary for regulatory activities. Mention its five-level hierarchy: LLT, PT, HLT, HLGT, SOC, and its role in consistent coding and analysis.

4. 4

   What are the expected reporting timelines for serious and non-serious adverse events in India and other regions?

   For India, serious events: 15 calendar days to CDSCO and 7 days for fatal/life-threatening; non-serious: 90 days. For US FDA, 15 days for serious unexpected; EU similar. Mention expedited reporting.

Practical Scenarios and Case Handling

1. 5

   You receive a report where a patient experienced nausea after taking a drug. The reporter is a nurse. How do you determine if it is serious and what actions do you take?

   Assess seriousness using ICH criteria. Nausea alone is usually non-serious unless it leads to hospitalisation or is life-threatening. Document, code, and follow up for missing information. If non-serious, process within 90 days.

2. 6

   A patient calls to report a side effect but does not want their details shared with the company. How do you handle this?

   Explain the importance of reporting for patient safety, obtain consent if required, and anonymise data as per privacy laws. If consent is refused, document the call and report only if regulatory requirements mandate it.

3. 7

   During literature screening, you find a case report of a rare adverse event not listed in the product label. What is your next step?

   Treat it as a valid case, enter it into the safety database, assess causality and expectedness, and if it is a serious unexpected event, expedite reporting. Also consider signal detection.

4. 8

   How would you handle a situation where you are unsure whether an event meets the criteria for 'medically significant'?

   Consult the product label, standard references, and a medical reviewer. Document the rationale and follow the company's SOP. When in doubt, treat it as serious until proven otherwise.

Behavioural and Situational Questions

1. 9

   Tell me about a time you had to pay close attention to detail to avoid an error. How did you ensure accuracy?

   Use STAR method. Highlight a situation where you double-checked data, followed a checklist, or caught a mistake. Emphasise your systematic approach and commitment to quality.

2. 10

   Describe a situation where you had to work under a tight deadline. How did you prioritise?

   Show time management and prioritisation based on regulatory urgency. Mention communicating with team members and using tools to track tasks.

3. 11

   How would you handle a disagreement with a senior colleague about the seriousness of a case?

   Demonstrate respect, evidence-based discussion, and willingness to escalate to a medical reviewer if needed. Focus on patient safety and compliance.

4. 12

   Why do you want to work in pharmacovigilance, and how do you see your career growing in this field?

   Express genuine interest in patient safety and regulatory science. Mention learning goals like aggregate reporting, signal detection, or becoming a subject matter expert.

HR and Company Fit

1. 13

   What do you know about Granules India and why do you want to join us?

   Research the company's products, global presence, and recent news. Connect your skills to their pharmacovigilance needs and show enthusiasm for their growth.

2. 14

   How do you stay updated with changing pharmacovigilance regulations?

   Mention sources like CDSCO, FDA, EMA websites, industry journals, webinars, and professional groups. Show proactive learning.

3. 15

   Are you comfortable working in shifts or handling high volumes of cases during peak periods?

   Be honest but positive. Emphasise adaptability, time management, and commitment to meeting deadlines without compromising quality.

4. 16

   Where do you see yourself in five years in this role?

   Show ambition aligned with the company's growth. Mention gaining expertise in case processing, moving into aggregate reporting or signal detection, and possibly leading a team.